Product Information
IMATINIB MESYLATE 400 MG TAB is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $2.8764 per EA under NDC 82009008730. Its NADAC has been published 143 times since Nov 29, 2023.
FDA first approved this application on Jul 23, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009008730
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA212773FDA Approved
7/23/2020
TE Code
AB
On Market Since
9/1/2023
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 400 MG TAB has been published 143 times since Nov 29, 2023, and over the history we have for it it has risen 61.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8764 per EA |
|---|---|
| All-time high | $3.2150 (Mar 11, 2026) |
| All-time low | $1.5602 (Jan 17, 2024) |
| 52-week high | $3.2150 |
| 52-week low | $2.8764 |
| Median price | $2.6303 |
| Average price | $2.5356 |
| Largest weekly change | +27.4% (Jun 19, 2024) |
| Weeks tracked | 143 |
| Tracking since | Nov 29, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 400 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 400 MG TAB, manufactured by Quallent Pharmaceuticals Health LLC, is $2.8764 per EA (NDC 82009008730), effective Aug 19, 2026.
How has the price of IMATINIB MESYLATE 400 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 400 MG TAB has risen 61.6%. It has been tracked across 143 weekly CMS publications since Nov 29, 2023.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 400 MG TAB?
Since Nov 29, 2023, the NADAC for IMATINIB MESYLATE 400 MG TAB has ranged from a low of $1.5602 (Jan 17, 2024) to a high of $3.2150 (Mar 11, 2026), with a median of $2.6303 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 400 MG TAB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IMATINIB MESYLATE 400 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures IMATINIB MESYLATE 400 MG TAB?
IMATINIB MESYLATE 400 MG TAB (NDC 82009008730) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.